Guardant Health
GH
#3827
Rank
$2.63 B
Marketcap
$21.38
Share price
0.19%
Change (1 day)
-22.62%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Revenue for Guardant Health (GH)

Revenue in 2024 (TTM): $0.64 Billion USD

According to Guardant Health 's latest financial reports the company's current revenue (TTM ) is $0.64 Billion USD. In 2023 the company made a revenue of $0.56 Billion USD an increase over the revenue in the year 2022 that were of $0.44 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Guardant Health from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $0.64 B14.16%
2023 $0.56 B25.45%
2022 $0.44 B20.31%
2021 $0.37 B30.32%
2020 $0.28 B33.75%
2019 $0.21 B136.52%
2018 $90.63 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$1.36 B 111.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.91 B 41.69%๐Ÿ‡บ๐Ÿ‡ธ USA